Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises OptiGroup AB in acquisition of Stadsing A/S.
Mandate

Vinge advises OptiGroup AB in acquisition of Stadsing A/S.

July 10, 2017

Vinge advises OptiGroup AB (former Papyrus Holding AB) in connection with its acquisition of Stadsing A/S. 

Stadsing is one of the leading suppliers of cleaning, hygiene and facility supplies in Denmark. The transaction was completed following approval from the Danish competition authority.

Vinge´s team consisted of Christina Kokko (M&A), Anna Palmérus (competition law), Oscar Rydén and Johanna Wiberg.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026